Wipfli Financial Advisors’s Organogenesis Holdings ORGO Stock Holding History

Wipfli Financial Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5K	Buy	+1,585	New	+$7.16K	﹤0.01%	2084

Other funds holding ORGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wipfli Financial Advisors's ORGO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Organogenesis Holdings (ORGO) in Q3 2022: 1,585 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #2084 among its holdings.

154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

Wipfli Financial Advisors held 1,585 shares of Organogenesis Holdings worth $5K as of Q3 2022.
Organogenesis Holdings was a new Wipfli Financial Advisors position in Q3 2022.
Organogenesis Holdings made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2084 holding.
154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.